-transparent.png){kind=logo}
There is considerable evidence that substance P (SP) is a neurotransmitter in the CNS. Current findings suggest that the effects of synaptically released SP are terminated by enzymatic breakdown, primarily by endopeptidase 3.4.24.11 (endo 24.11). The products of cleavage by endo 24.11 include the amino-terminal fragment SP(1-7). Evidence suggests that SP is involved in mediating baroreceptor reflex activity in the nucleus of the solitary tract (NTS). Microinjection of SP into the NTS lowered blood pressure and heart rate. Microinjection of SP(1-7) into the NTS reproduced the effects of SP on both heart rate and blood pressure. Intra-NTS injection of phosphoramidon, an inhibitor of endo 24.11 activity, completely blocked the effects of a subsequent injection of SP. This blocking effect of phosphoramidon was unaltered by pretreatment with the opiate inhibitor naloxone. In contrast, phosphoramidon failed to block the depressor and bradycardic effects of SP(1-7). The implications of these findings regarding the role of endo 24.11 in the metabolism of SP are discussed.
M E Hall, and
F Miley, and
J M Stewart
January 1953,
Acta physiologica Scandinavica. Supplementum,
M E Hall, and
F Miley, and
J M Stewart
January 1956,
Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie,
M E Hall, and
F Miley, and
J M Stewart
January 1991,
Annals of the New York Academy of Sciences,
M E Hall, and
F Miley, and
J M Stewart
March 1978,
Science (New York, N.Y.),
M E Hall, and
F Miley, and
J M Stewart
January 1993,
Biochemical pharmacology,
M E Hall, and
F Miley, and
J M Stewart
February 1979,
Neuropharmacology,
M E Hall, and
F Miley, and
J M Stewart
June 1990,
Brain research,
M E Hall, and
F Miley, and
J M Stewart
June 1981,
Clinical physiology (Oxford, England),
M E Hall, and
F Miley, and
J M Stewart
January 1982,
Advances in biochemical psychopharmacology,
M E Hall, and
F Miley, and
J M Stewart
April 1991,
Neuropeptides,
